U.S. markets open in 6 hours 18 minutes

RAMM Pharma Corp. (RAMM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.7000-0.0500 (-6.67%)
At close: 10:56AM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7500
Open0.0000
Bid0.6500 x N/A
Ask0.7000 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume48,173
Market Cap69.62M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid
      GlobeNewswire

      RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

      TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces its intention to commence a normal course issuer bid (the “NCIB”), under which it may purchase up to 5% of the current number of issued and outstanding common shares of the Company (the “Common Shares”). The NCIB may commence on or about July 12, 2021 and shall expire on the 12-month anniversary of the effective date of the NCIB. All Common Shares

    • RAMM Pharma Completes Acquisition of Canapar Corp.
      GlobeNewswire

      RAMM Pharma Completes Acquisition of Canapar Corp.

      TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Further to its news releases dated May 12 and June 14, 2021, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has completed its previously announced acquisition of Canapar Corp. (“Canapar”). Pursuant to the terms of the acquisition, RAMM acquired of all the common shares of Canap

    • Canapar Corp. Receives Shareholder Approval for Business Combination With RAMM Pharma
      GlobeNewswire

      Canapar Corp. Receives Shareholder Approval for Business Combination With RAMM Pharma

      TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Further to its news release dated May 12, 2021, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, together with Canapar Corp. (“Canapar”), are pleased to announce that, at the special meeting of shareholders of Canapar (the "Canapar Shareholders"), the Canapar Shareholders overwhelmingly voted in favour of the special r